Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of anti-inflammatory and analgesic agents. Its structure supports the creation of compounds with enhanced metabolic stability due to the presence of the trifluoromethyl group. Commonly employed in medicinal chemistry for designing inhibitors targeting specific enzymes involved in pain and inflammation pathways. Also utilized in the preparation of radiolabeled derivatives for drug metabolism studies.